Research & Clinical Trials - Page 8
BAP1 Mesothelioma Mutation Focus of Upcoming Clinical Trial
- by Tim Povtak
- Research & Clinical Trials
- Jul 5, 2017
Researchers at the University of Hawaii believe they are close to a fix for the genetic mutation that makes certain people more susceptible to developing mesothelioma cancer and more resistant…
Read More
Seattle Cancer Center Opens Latest Mesothelioma Clinical Trial
- by Tim Povtak
- Research & Clinical Trials
- Jun 27, 2017
The Seattle Cancer Care Alliance has opened a phase II clinical trial involving durvalumab, the promising immunotherapy drug, in combination with chemotherapy for the first-line treatment of unresectable pleural…
Read More
Time Between Surgeries Helps Predict Mesothelioma Survival
- by Matt Mauney
- Research & Clinical Trials
- Jun 23, 2017
A new study from researchers at the City of Hope cancer center in Los Angeles and Wake Forest University School of Medicine in Winston-Salem, North Carolina, reveals how the length…
Read More
Can a Breath Test Diagnose Mesothelioma in the Early Stages?
- by Matt Mauney
- Research & Clinical Trials
- Jun 20, 2017
Much of mesothelioma research centers on identifying new and noninvasive biomarkers for earlier detection of the asbestos-related cancer. Progress has been made in finding biomarkers in blood and…
Read More
Mesothelioma Clinical Trial Opens with High Expectations
- by Tim Povtak
- Research & Clinical Trials
- Jun 16, 2017
Newly diagnosed mesothelioma patients around the world have begun enrolling in a much-anticipated, phase III clinical trial involving an immunotherapy drug combination with groundbreaking potential. The trial, designed…
Read More
How Math Is Reshaping Mesothelioma Chemotherapy
- by Matt Mauney
- Research & Clinical Trials
- Jun 13, 2017
Economists, physicists and engineers use mathematical models extensively in their respective industries. Now, French researchers are using mathematical modeling as a tool to optimize cancer treatments for mesothelioma patients.
Read More
Using Viruses to Boost Mesothelioma Immunotherapy
- by Matt Mauney
- Research & Clinical Trials
- Jun 6, 2017
Immunotherapy through clinical trials is becoming a promising treatment option for some mesothelioma patients. Checkpoint inhibitor drugs, such as Keytruda, already have U.S. Food and Drug Administration (FDA) approval…
Read More
Methanol from African Plants Kills Mesothelioma Cells
- by Matt Mauney
- Research & Clinical Trials
- Jun 2, 2017
Methanol, or methyl alcohol, is a colorless solvent found in a variety of automotive products including windshield washer fluid, gasoline antifreeze and alternative fuels. It is also used as an…
Read More
New Study Hopes to Improve Early Detection of Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- May 30, 2017
Researchers in Germany have developed a novel blood test for mesothelioma cancer that could lead to earlier detection of the disease and a better prognosis for patients. The test…
Read More
Mesothelioma Study Using Fitbit to Monitor Patient Recovery
- by Matt Mauney
- Research & Clinical Trials
- May 23, 2017
Millions of Americans use Fitbit devices to track their daily activities, exercise and sleep patterns. But a student intern at the Pacific Heart, Lung & Blood Institute (PHLBI) in California…
Read More
